The training will be delivered by the referral team and is open to all vet nurses, trainee vet nurses and animal care assistants, with content for all experience levels.
Topics on the day include:
Eleri Counsell, Nursing Manager at Langford, said: “The Congress has gone from strength to strength since it was launched in 2022.
"Our aim has been to showcase our outstanding nursing team here at the Small Animal Referral Hospital and continue to support our local referring practices and the wider veterinary nursing community by sharing our expertise.
"The nurses have really been the driving force for this Congress and their passion when talking about their areas is inspiring.”
Tickets cost: £150
https://www.eventbrite.co.uk/e/vet-nurse-congress-2024-tickets-793211144887
The new guidelines are freely available in the Journal of Feline Medicine and Surgery (JFMS), along with new consensus guidelines for vets and a guide for caregivers.
Samantha Taylor, iCatCare Veterinary Specialist Consultant and co-author and panel chair for the guidelines said: “There have been significant developments in the treatment of feline diabetes mellitus since the publication of the 2015 ISFM diabetes guidelines.
"Experts in the disease from the USA, Netherlands, UK, Australia and Italy have collaborated on a much-needed update and the resulting 2025 iCatCare consensus guidelines are an essential information resource for vets diagnosing and treating diabetes mellitus in cats.”
https://internationalcatcare.cmail20.com/t/i-l-znwll-tykyklax-k/
Visitors will be given a behind-the-scenes look and have the opportunity to chat with Specialist surgeons Former Member and Chris Jordan.
Andy said: “We have had a fantastic first six months, and to say thank you to those who have referred cases to us, and to show off our facilities to those who haven’t seen the clinic, we are thrilled to be holding an open evening.
"I’m looking forward to providing tours of the clinic and having a chance to talk to vets about our services and how we can help.”
All veterinary professionals and their families, and pet owners are welcome.
The clinic is situated just off the M3 and 30 minutes from the M25, in the village of Upton Grey, near Basingstoke.
To register your interest and book a place at the open day please contact Marie at Marie@mooresortho.com or 01256 632100.
The referral centre has invested in a new heart and lung machine, and an oxygen cage, and is expected to take its first patients in the autumn.
The service will be established and led by head of cardiac surgery Poppy Bristow (pictured right) and head of cardiology Anne Kurosawa, who have already performed this kind of surgery on more than 100 dogs to date.
DWR is also setting up its own blood transfusion service to collect blood from staff and clients’ pets to support the service.
The blood collected will also be used to support the practice’s emergency and critical care service and its planned dialysis programme.
Poppy said: “There are hardly any other centres in the world offering this type of surgery, especially with this level of expertise that comes from the collective team we have gathered at DWR.
“Mitral valve disease is the most common heart condition in dogs and sadly, many dogs die every year as there are very few options for treatment. To be able to offer surgery to more dogs and their owners is really exciting.
“DWR is the perfect environment for this pioneering programme, due to the state-of-the-art equipment and depth of expertise on hand to support this life-saving initiative.”
Rob Foale, clinical director at Dick White Referrals, added: “It’s a hugely significant step for us to be launching this service, drawing on Poppy’s expertise in this field.
“We’re also starting our own blood transfusion service to complement the launch, as the pandemic has led to a huge drop in pet blood donations.
“Any excess blood we collect will be donated to the national Pet Blood Bank charity, which supplies blood to veterinary practices across the UK and does a fantastic job.”
For more information, visit www.dickwhitereferrals.com.
The practice is now accepting dental referrals, including for dental, oral and maxillofacial surgery.
Hannah said: “I am proud to join the Fitzpatrick Referrals team to extend their referral offering to include this very important aspect of small animal veterinary treatment.
"Working alongside a world-class team with state-of-the-art facilities is a fantastic opportunity.”
https://www.fitzpatrickreferrals.co.uk/services/dentistry/
The expansion has increased the hospital's footprint by 30%, adding three new operating theatres, six new consult rooms and new feline facilities, including a cat-only waiting room, consult room and treatment area.
Hospital owner, IVC Evidensia said the expansion has been driven in part by the pet ownership boom of the last few years and increased demand for the hospital’s services.
To meet the demand, Vale has expanded its office space, adding desk space for a further 25 vets.
There are also new ultrasound and cardiology rooms, a new dental suite and enlarged prep and recovery areas.
The existing kennel area has doubled in size with the addition of nine new walk-in kennels, a bespoke isolation ward and secure outdoor runs.
Richard Artingstall, clinical director at Vale Referrals, said: “We’ve been working on this expansion for a long time and it’s incredible to see it complete.
"Our new and improved facilities mean we can give even more pets across the Southwest the gold standard treatment that they deserve and support our colleagues from neighbouring vet practices with extensive referral services.
"The feedback from pets and owners so far has been very rewarding to hear.”
The feedback from pets?
Really?
VetSurgeon.org contacted recent patient Dougal McDoggins for comment.
He said: "Woof."
www.valereferrals.co.uk.
APPA is an oral, patented, fixed-dose combination of two synthetic secondary metabolites of plant origin, apocynin and paenol.
Under the terms of the agreement, AKL’s unnamed partner will fund a study in dogs with naturally occurring OA. The study will compare the efficacy and efficacy duration of APPA with the current standard of care for treating canine OA: non-steroidal anti-inflammatory drugs.
David Miles, AKLRD CEO, said: “Just like humans, millions of dogs suffer intolerable pain and disability because of OA and the current treatments just aren’t as effective or as well tolerated as they need to be. We already know from previous canine studies that APPA reduces pain and has an excellent tolerability profile but this exciting new partnership will allow us to go one stage further and assess sustainability of response.”
The randomised study will assess pain and duration of response as the primary endpoint. Secondary endpoint assessment will include adverse events, quality of life, pharmacokinetics analysis and biomarkers that may enable potential identification of factors predictive of response at treatment onset, or that correlate with response magnitude.
Two separate studies on dogs have already been carried out by researchers at the University of Vienna. The first, an 11-week cross-over study of 32 canines diagnosed with established, naturally occurring OA, showed that APPA provides significant symptom relief in clinical canine OA1.
A follow-up, five-week study of 60 dogs with OA compared APPA to the standard of care drug, meloxicam. It concluded that daily oral administration of APPA was effective as a stand-alone alternative to NSAIDs in dogs with naturally occurring OA. Significant benefits were also seen for APPA over meloxicam in orthopaedic examination as well as in lameness and function scores2.
The results will inform the pivotal clinical trial design and AKL says its working assumption is that a 26-week field study would complete the regulatory requirements for commercialisation.
If the study and future testing is successful, AKL estimates that APPA would be well placed to capture a significant share of the global canine OA market, which is estimated to be worth $3billion by 20283.
References
Nominations will remain open until 5pm on Tuesday 31 January 2023 and the elections will take place in March and April 2023.
VN Council and its members are responsible for all matters concerning veterinary nurse training, post-qualification awards and the registration of qualified veterinary nurses, as well as the joint RCVS and British Veterinary Nursing Association (BVNA) VN Futures project.
Matthew Rendle, Chair of VN Council and an elected member since 2016, said: “As the stature of veterinary nurses has grown over the years, so too has VN Council and the VN Education Committee, with members taking decisions on the accreditation of veterinary nursing education providers, new qualifications, matters relating to the registration of veterinary nurses, as well as having strategic oversight of the VN Futures project and its mission to ensure that veterinary nursing is a vibrant, rewarding and sustainable profession.
“As a member of VN Council you will have a great opportunity to travel around the UK meeting your fellow nurses and getting fresh perspectives on what it means to be a VN, with a particular highlight being welcoming new veterinary nurses to the profession through our many registration and graduation ceremonies.”
The full eligibility criteria, info and FAQs for vets who want to stand can be found at: www.rcvs.org.uk/vncouncil23
Prospective candidates for VN Council can contact Matthew Rendle for an informal conversation on what it means to be an RCVS Council member on: vncchair@rcvs.org.uk
There is also an agenda of previous VN Council meetings at www.rcvs.org.uk/who-we-are/vn-council/vn-council-meetings/ for those who want to see examples of the kind of business it conducts.
The Association says it has produced the leaflet after seeing an increasing number of dogs diagnosed with clinical or subclinical infection, along with reports of its zoonotic impact.
The document outlines the most important considerations concerning B. canis including transmission, diagnosis, management, public health implications and legislative requirements.
It takes into consideration information available from relevant Government Departments.
BSAVA says the document is by no means exhaustive but is intended to provide useful information and signpost to further resources.
www.bsavalibrary.com/brucella_canis
Photo: Walker16/Wikipedia. CC BY-SA 4.0.
The company says the Elekta Infinity linear accelerator is the only one of its kind for pets in England.
It features a multi-leaf collimator for very accurate shaping of the radiation beam and a six-degrees-of-freedom couch top designed so the patient can be positioned to reduce or eliminate radiation doses to critical organs.
CVS says the new machine will allow the centre to offer cutting edge treatments such as stereotactic radiation therapy, where high dose rates of focused beams are delivered with high precision over a shortened treatment course.
This, the company claims, will mean fewer, shorter sessions, fewer side effects and the best possible chance of improved outcomes for the animal.
Delphine Holopherne-Doran, Clinical Director at Bristol Vet Specialists, said: “Our new hospital will be at the forefront of cancer care in animals.
“The linear accelerator is state of the art, and allows us to offer advanced, image-guided radiation treatments - for example intensity-modulated or stereotactic radiation therapy.
"The advantage to these treatments is that they will allow a more “hard-hitting” treatment of the tumour, with greater safety for the patient’s healthy tissue.
"It will draw many tumours into the realm of treatability.”
Based at Central Park, Avonmouth, Bristol Vet Specialists referral hospital is due for completion this Autumn.
CharcoPet is a ready-to-use oral gel formulated with 50% activated charcoal and marine-derived polysaccharides.
Forte says Charcopet has a high concentration of activated charcoal per ml, which reduces the volume needed and minimises handling stress.
It's supplied in a 2 x 30ml dial-dose syringes, with each syringe suitable for up to 15 kg bodyweight, used at 2 ml/kg bodyweight orally, repeatable every 4–6 hours if clinically required.
Dr Lucy Chadwick MVB ACIM CMktr MRCVS, Global Partnerships Manager & Head of Technical Services at Forte Healthcare said: “CharcoPet represents a major step forward in veterinary care, offering practitioners a fast, precise, and reliable solution when faced with suspected or confirmed cases of toxin or medication ingestion."
https://fortehealthcare.com/product/charcopet/
Improve Veterinary Education will maintain its core mission and quality promise: to deliver all postgraduate training and education programmes for vets and vet nurses through face to face, online learning, blended learning and short course options.
Improve Veterinary Practice offers an online knowledge hub so veterinary professionals can access the latest advice, news and information across all specialties.
Membership also offers ways to keep track of and meet your annual CPD targets.
ISVPS assesses our training programmes and awards globally recognised postgraduate veterinary qualifications to both vets and vet nurses in a range of clinical subjects.
Katie Hungerford, Director of Marketing at Improve International Group, said: “We have modernised all aspects of the Improve International Group to reflect our movement towards providing more online and blended learning choices.
"The experience for veterinary professionals will now feel coherent with simplified graphics and information, no matter which part of the business they need to use.”
The operation of the equipment is being overseen by Dr Rodney Ayl, a specialist in both medical and radiation oncology. He said: "The need for protection of personnel during preparation of cytotoxic drugs presents the most significant obstacle to the safe provision of chemotherapy, as most practices are not equipped with an appropriate biosafety cabinet. This is especially true when there is a high case-load of chemotherapy patients."
Dr Ayl says the dangers of repeatedly handling and administering cancer drugs can be severe. He added: “The likelihood of drug exposure must be taken into account when considering the safety of personnel who handle cytotoxic drugs.
"The cumulative toxicity to personnel that arises from repeated contact with these drugs can cause health problems in the nursing staff that are beyond those expected in the patient.
"The main routes of personnel exposure to cytotoxic drugs are by aerosolisation or by absorption through skin.
"Both types of exposure can occur when preparing drugs for administration. The act of withdrawing cytotoxic drug from the vial into a syringe is generally the step that presents personnel with the greatest potential for exposure to a high concentration of drug.
"Ideally, personnel are optimally protected from drug exposure, and patients are protected from contamination of the product, by the use of a laminar flow biosafety cabinet (BCS) during drug preparation, regardless of whether a closed delivery system is used.
"The Envair CytoFAST BSC has been designed to guarantee the product, personnel and environmental protection.
"It belongs to the latest generation of laminar airflow systems and is built to the highest quality to guarantee the strictest safety standards - and the safety of our people is paramount at Paragon."
The new RUMA Companion Animal and Equine Group will initially focus on encouraging efforts to promote responsible antibiotic use.
Steve Howard, head of clinical services at the People’s Dispensary for Sick Animals and secretary general of the new group, said: "RUMA has spearheaded successful efforts to steward antibiotic use in farmed animals over the past five years, and we would like to see whether its principles can augment the considerable progress that’s already been made in the companion animal and equine sectors.
"The most notable of RUMA’s initiatives is the Targets Task Force, which has seen leading vets and farmers from each species working together with industry groups to develop meaningful goals for reducing, refining or replacing antibiotic use.
"Through establishing such proactive approaches towards antibiotic stewardship in companion animals and equines, we hope to optimise their health and welfare – as well as that of humans and the environment."
RUMA says that although total antibiotic sales are significantly lower for companion animals compared with the farming sector, even relatively low use can result in resistance to key medicines if good stewardship principles are not applied.
The collaboration will cover use of medicines in dogs, cats, rabbits, small mammals, exotic animals kept as pets, and equids. The aim is for the UK to lead the way in these sectors through evidence-based and measurable activities that will promote and enhance stewardship.
Gwyn Jones, chair of the new group (pictured right), said: "As a collaborative group we need to establish evidence-based protocols for reducing, replacing or refining antibiotic use in companion animals, to further help preserve and prolong the use of these vital tools for human and animal health.
“Efforts will be focused towards identifiable goals so that progress can be monitored and demonstrated. But we will also promote practical, practice-level resources, guidance and measures aimed at driving positive behaviour changes and protecting patients and practitioners alike."
The authors say that study seeks to redress the lack of evidence-based information that has so far been published on the epidemiology and clinical management of non-neoplastic anal sac disorders (ASD).
The study, which was carried out within the RVC’s VetCompass programme, focused especially on identifying breeds with increased or reduced risk of anal sac disorders.
The breeds at greatest risk of an anal sac disorder compared with crossbreeds included Cavalier King Charles spaniel, King Charles spaniel and Cockapoo.
Conversely, breeds at reduced risk included larger breed dogs including Boxer, German Shepherd Dog and Lurcher. Flat-faced (brachycephalic) breeds such as Shih Tzu had 2.6 times the risk for anal sac disorders compared to long-skulled breeds such as Border Collies. Spaniel-types, Dachshund-types and Poodle also showed increased risk for anal sac disease.
The study identified 2,372 anal sac disorder cases from a population of 104,212 dogs attending VetCompass participating practices during 2013.
Other findings included:
Dr Dan O’Neill, Senior Lecturer, Companion Animal Epidemiology, at the RVC, and author of the paper, said: “During two decades in first opinion practice, anal sac problems in dogs were a routine daily presentation for me. However, when I searched the literature to find evidence on the best way to treat these dogs or even on which breeds were at most risk, there was almost no information available. It seemed back then that only problems that were severe enough to be referred to universities in large numbers were researched.
"As a result, vets in first opinion practice generally had to work out for themselves what seemed to be the best treatment in these cases. It is refreshing now to see research on common problems in dogs under first opinion veterinary care being reported. Owners and vets needs this evidence vitally.”
Anette Loeffler, Associate Professor of Veterinary Dermatology at the RVC and co-author of the paper, said: "This study shines a spotlight on critically important area of veterinary practice: antibiotic usage. Twenty percent of dogs presenting with an anal sac disorder received antibiotics even though diagnostic criteria for anal sac infection or proof of efficacy of antibiotic treatment are lacking.
"At a time when antimicrobial resistance presents one of the biggest threats to human and animal health, this highlights an urgent need for further study of these disorders in order to improve dog welfare but also to help vets in making responsible antibiotic treatment decisions in the interest of public health.”
The academy will consist of three modules which will be launched in 2021. Those who complete all three modules will receive certification from Bimeda, and some exclusive branded goodies.
The first module is titled Bimeda Trace Elements in Dairy Cow Fertility & Pregnancy and is available now on Bimeda’s e-learning portal: https://bimeda-learning.co.uk. This module also accounts for 1 hour 15 minutes of CPD and vets can download a certificate when they complete the module. The module has also been accredited with 9 AMTRA points.
In the coming months Bimeda says it'll add a second module focused on the role of trace element nutrition in lamb and calf growth, and a final module focused on the role of trace elements in sheep fertility and pregnancy.
Bimeda UK General Manager Mark Cokayne said: "Trace elements play a critical role in the health and fertility of ruminants, yet historically this area has been somewhat overlooked in formal animal health education.
"Our customers tell us that they would like a deeper understanding of areas such as trace element deficiencies, toxicities and interactions, and the impact of these on ruminant health and fertility. We are pleased to respond to this market demand with our new academy, which will provide veterinarians and SQPs with additional knowledge to help inform their conversations with farmers."
To sign up to either Bimeda’s online Nutrition Academy or the Sheep Scab Academy, visit https://bimeda-learning.co.uk
For more information, speak to your Bimeda territory manager or call Bimeda on 01248 725 400.
Titled ‘The Five Steps of Seizure Management’, the sessions will update veterinary surgeons and nurses on:
Will Peel, Product Manager at TVM UK said: "The Lunch and Learn sessions have proved very popular with veterinary practices. Our aim is to update vets and nurses on diagnosis and management of epilepsy in general practice whilst educating them about products and services which can help them better support their patients."
TVM says it will also provided supporting literature, including guidelines and owner educational tools, designed to help veterinary staff in diagnosing and treating pets with epilepsy.
To book a Lunch and Learn, contact your local TVM UK territory manager or email help@tvm-uk.com.
The company says the return to a ‘new normal’ post-lockdown provides a significant opportunity for practices to apply a renewed focus to preventative healthcare, recommending parasiticides as a way to improve animal welfare and generate practice revenue, which is vital for economic recovery.
Caitrina Oakes, Vetoquinol Managing Director UK and Ireland, said: “With many pet owners spending more hours than ever with their pets during lockdown, companion animal parasiticides have never been more important – making Profender and Drontal highly relevant in the current environment.”
She added: “It’s a very challenging time for many veterinary practices as everyone adapts to the post-COVID world. I’m looking forward to seeing how the passion and ambition we bring to our brands helps Profender and Drontal to grow and helps us to better serve the needs of the veterinary community, both now and in the future.”
Up to date information on the brands and their distribution can be found on the Vetoquinol website, www.vetoquinol.co.uk, by calling 01280 814500, or practices can contact their Vetoquinol Territory Manager directly.
To raise the funds, CVS put customer and staff collection boxes in its small animal first opinion practices and referral hospitals.
Staff also held a number of fundraising events – including sponsored walks and dog shows, as well as hosting Pet Blood Bank donation days.
The money raised from the partnership will help go towards funding Pet Blood Bank’s work.
Last year the charity sent over 5,000 units of blood to vets across the UK.
Pet Blood Bank provides training for vets and nurses, and donations also help the charity to keep the cost of blood products as low as possible, and provide them free to veterinary charities.
Deputy Chief Executive of CVS Group, Ben Jacklin, said: “Pet Blood Bank is a vital charity doing crucial work within our profession.
"There is no doubt that the level of funds raised is down to the tireless commitment shown by our colleagues up and down the country.
"I’d also like to recognise the role our clients have also made - as without them we would never have reached such a great total.”
Managing Director of Pet Blood Bank, Katrina Wilkinson said: “This generous donation from CVS Group has been incredible to receive.
"We are a small charity so need all the support we can get, and CVS has truly delivered."
CVS has recently announced its next charity partner as Guide Dogs for the Blind.
The route covers a distance of approximately 400 miles.
Oscar said: “My goals for the event are to raise awareness about mental health within the veterinary profession and demonstrate how being in the countryside can boost wellbeing. Along the way, I’m keen to fundraise as much as possible for Vetlife.
“Vetlife has done so much for the veterinary profession with regards to making mental health support more accessible.
"Having that knowledge that they are there personally provides a lot of comfort in what can sometimes be quite a lonely and isolating profession.”
Fellow cyclist and Vetlife trustee Danny Chambers said: “I know how painful it is to cycle up Cheddar Gorge in North Somerset, so I am in awe that Oscar is cycling a 400-mile route around that terrain to visit every vet practice in Somerset in 2 days.
"I’m sure in his brief visits to each practice he’ll get a warm welcome and some sustenance to help him along to his next pit stop!
"Thank you to Oscar for his enthusiasm and support.”
Oscar is inviting others in the veterinary community to join sections of the journey along the way.
For more information on how to get involved with the cycle, visit the Somervet Facebook group: https://www.facebook.com/groups/1930480070643515.
Donate to the fundraiser via the Somervet JustGiving page: https://www.justgiving.com/page/ride-somervet
The 2022 programme will include 17 education streams, covering the veterinary and nursing care of companion animals, together with a stream covering veterinary wellness, leadership and management-related topics.
Speakers include veterinary experts and leaders from around the world, and the expected 2,000+ delegates will be able to collect 14 hours of CPD over the two days.
The VET Festival will also offer a Wellness Hub offering things like yoga, movement and mindfulness sessions alongside the lectures.
There'll be a diverse commercial exhibition, with more than 60 leading veterinary suppliers, and all delegates will also have free admission to the VETFest Live Party Night.
Noel Fitzpatrick, Clinical Chair at Fitzpatrick Referrals, who launched VET Festival in 2015, said: “The last 18 months have been tough for everyone but particularly difficult for veterinary professionals, many of whom were already suffering with challenges to their well-being and mental health because of the pressures of their work.
"VET Festival is an oasis of time during which they can relax and rejuvenate themselves; experiencing continuing professional development that is uplifting and inclusive and enjoying social activities and companionship that will replenish their souls.”
Tickets for VET Festival can be bought here: https://www.vetfestival.co.uk/delegate-info/ticket-information
The new brand has a couple of display stands that practices can use to show off the range of memory boxes, paw print kits, paw moulds, fur/hair bottles, plant markers and forget-me-not seeds, and hanging/seasonal decorations.
Oh So Precious is the brainchild of Helen Davies, founder of The Lovely Gift Group (pictured right).
She said: “Having lost pets myself and sold many keepsakes, I know how much emotion and passion we put into our relationships with them.
“When my daughter asked for a keepsake for her best friend I realised their was a gap in the market.
“We also identified a need for good quality, pet related items through our existing gift customers.
"We learn a lot from them and they continually highlight requirements for themselves and as thoughtful gifts for friends who have lost pets.
"The unity among pet owners – that need to convey an understanding and appreciation for those suffering the pain of pet loss - is very real.”
Helen says that as well as providing a new revenue stream, the range will help practices meet client needs and provide new ways to be empathetic to clients in times of distress.
There will be a special show offer for orders taken at The London Vet Show, and in 2023 the team is planning to launch personalised pet keepsakes via links from vet practice websites.
www.ohsoprecious.co.uk
Kaminox contains potassium gluconate and B-vitamins to help dogs affected by hypokalaemia.
Originally released as an oral liquid supplement, Vetplus says this new powdered formulation offers a more concentrated level of potassium for larger pets or those that require a higher dose.
Kaminox sachets are sold in packs of 30, with a scoop provided for easy administration.
Meanwhile, the liquid supplement is available in 60ml and 120ml bottles.
www.vetplus.co.uk/products
It is the first time BVRA has recognised an external veterinary group’s own receptionist training programme as adequate enough to award AVR status.
The AVR status is normally only awarded after the completion of the BVRA’s Level 3 Certificate for Veterinary Receptionists and other approved BVRA training - usually completed over a 1-2 year training period.
CVS’ Level 4 Endorsed Certificate in Veterinary Client Care is for its experienced receptionists with at least one year’s experience.
The training covers a wide range of skills and knowledge including; client care, finance, preventative healthcare, bereavement support, self-leadership and working with others.
Philip Webb, Learning Partner at CVS who helped to design its Level 4 Endorsed Certificate in Veterinary Client Care, said: “We value our receptionists highly.
"Being eligible for Associate Veterinary Receptionist will be of huge benefit to them. It will give them the status and recognition they deserve and will give them access to many AVR benefits - including ongoing access to additional CPD and professional and industry developments."
The paper details the current and potential uses of this rapidly developing technology, and its benefits and risks.
It provides an introduction to AI and its uses in human medicine, small animal, farm and equine practice, radiology and veterinary education.
It also looks at the potential impact on the wellbeing and working life of veterinary teams.
Results from VetCT’s recent survey on the opinions of AI within the veterinary profession are included in the paper.
Julien Labruyère, Chief Innovation Officer at VetCT, said: “This is a crucial moment in the veterinary industry to ensure we have the knowledge and safeguards in place to apply AI safely, effectively and with confidence to support good clinical practice and ultimately, improve animal welfare.
"This white paper aims to provide a firm foundation for understanding AI and stimulate discussion on how it may impact both people and animals.”
The paper also calls for the development of industry-wide guidance, standards and regulations to safeguard veterinary teams and animal health and welfare as these tools are deployed.
Julien added: “AI development is accelerating rapidly, with global governments and industries racing to regulate to ensure the benefits outweigh the potential negative impacts of this far-reaching technology.
"It’s vital that opinion leaders, organisations and regulators from across the veterinary world come together and develop guardrails so we can have confidence that AI tools will benefit our teams and our patients.”
https://5345458.hs-sites.com/vetct-ai-white-paper